the Safety and Efficacy Evaluation of HGI-001 Injection in Patients With Transfusion-Dependent β-Thalassemia

NCT05864170 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

3

Enrollment

INDUSTRY

Sponsor class

Conditions

β-thalassemia

Interventions

BIOLOGICAL: β-globin restored autologous hematopoietic stem cells

Sponsor

Shenzhen Hemogen